3 Small-Cap Stocks Under Discussion – BUD, 4DS And CCA

3 Small-Cap Stocks Under Discussion - BUD, 4DS And CCA

Below mentioned Small-cap Stocks have released significant updates today (31 January 2019), due to which these stocks were one of the most discussed stocks by the investors. Let’s take a closer look at these stocks-

Buddy Platform Limited (ASX: BUD)

Cloud-based solutions provider, Buddy Platform Limited’s (ASX: BUD) securities were voluntarily suspended on 29 January 2019 from quotation at the request of BUD, pending the release of an announcement regarding its arrangement with Digicel Group, its December Quarterly 4C Review (Q2FY19), and a proposed acquisition. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

Today (31 January), the company announced that it has terminated Digicel Group Limited’s exclusivity right under the reseller agreement with Digicel which spanned 27 markets in 26 territories across the Caribbean and Latin America region. The Reseller Agreement will otherwise continue unchanged; however, the Company will engage with additional resellers in these territories. Recently the company reported a three-year revenue forecast of A$20.1 million attributable to Digicel.

In the past six months, the share price of the company decreased by 26.92% as on 25 January 2019. BUD’s shares last traded at $0.095 on 25 January 2019 with a market capitalization of circa $104.1 million.

4DS Memory Limited (ASX: 4DS)

4DS Memory Limited (ASX: 4DS) is a semiconductor development company of nonvolatile memory technology, and it owns a patented IP portfolio, comprising 20 US patents granted and three patents pending. Today the company announced that imec, its development partner, has fabricated functional 300mm wafers on the same multi-million-dollar state-of-the-art production equipment used by high volume manufacturers of memory. Following this news, the share price of the company got uplifted by 40% by end of the trading session, settling at $0.063 with a market capitalization of circa $47.31 million on 31 December 2018.

The company’s Board is confident that detailed testing and analysis over the balance of Q1 2019 at 4DS’ facilities, will provide invaluable data to refine the fabrication processes required to produce a megabit test chip during 2019.

In the past six months, the share price of the company decreased by 49.44 percent as on 30 January 2019.

Change Financial Limited (ASX: CCA)

FinTech Solutions and Blockchain Investment Company, Change Financial Limited (ASX: CCA) has provided an update on December quarter activities today. During the December quarter, the company completed an external strategic review concluding a focus on completing the enterprise solution and monetizing its non-core businesses. During the quarter, the Company also completed Mastercard’s (NYSE:MA) third-party processor testing procedure. Further, the Company’s payments processing platform is now eligible for registration as a Mastercard third-party processor.

During the quarter, the company secured new funding from Altor Capital for up to A$4 million. The Company is also undertaking an entitlement offer to existing shareholders which will close on 13 February 2019. Post the quarter end; the Company monetized its equity investment in the Ivy Project for cash proceeds of US$1.5 million. After providing the quarterly update, the share price of the company increased by 20% as on 31 January 2019.

In the past six months, the share price of the company decreased by 87.36% as on 30 January 2019. CCA’s shares traded at $0.066 with a market capitalization of circa $4.71 million as on 31 January 2019.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report